ArticleBiomarker research2025

SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis.

Fanghui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.